A JAMA Psychiatry analysis estimates schizophrenia costs the U.S. $366.8B in 2024, with nearly 80% of costs driven by ...
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...
A study found fewer than 1 in 5 current or former smokers over 50 are getting the quick screening.
Advancing chronic kidney disease may raise risk of cognitive decline, with attention, memory and brain function impacted, new JAMA study reveals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results